Search Result "HKI-272"
HER-2 Positive Breast Cancer: What Else Beyond Trastuzumab-Based Therapy?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8 Issue: 5 Year: 2008 Page: 488-496
Author(s): Christian Widakowich, Phuong Dinh, Evandro de Azambuja, Ahmad Awada, Martine Piccart-Gebhart
4-Anilino-3-quinolinecarbonitriles: An Emerging Class of Kinase Inhibitors - An Update
Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 1 Issue: 4 Year: 2004 Page: 457-463
Author(s): Diane H. Boschelli
Reversible Covalent Binding of Neratinib to Human Serum Albumin In Vitro
Journal: Drug Metabolism Letters
Volume: 4 Issue: 4 Year: 2010 Page: 220-227
Author(s): Appavu Chandrasekaran, Li Shen, Susan Lockhead, Aram Oganesian, Jianyao Wang, JoAnn Scatina
Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 799-812
Author(s): Sarah Barton, Naureen Starling, Charles Swanton
Synthesis and Structure-Activity Relationships of Potent Antitumor Active Quinoline and Naphthyridine Derivatives
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 685-709
Author(s): Sanjay K. Srivastava, Amrita Jha, Shiv K. Agarwal, Rama Mukherjee, Anand C. Burman
Efficacy and Tolerability of Vinorelbine in the Cancer Therapy
Journal: Current Drug Safety
Volume: 6 Issue: 3 Year: 2011 Page: 185-193
Author(s): Giuseppina Galano, Mariella Caputo, Mario Felice Tecce, Anna Capasso
Development of EGFR Family Small Molecule Inhibitors for Anticancer Intervention: An Overview of Approved Drugs and Clinical Candidates
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 38 Year: 2014 Page: 4374-4404
Author(s): Weiyan Cheng,Yongzhou Hu,Rong Sheng
NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 38 Year: 2017 Page: 4213-4228
Author(s): Domenico Trombetta,Antonio Rossi,Federico P. Fabrizio,A. Sparaneo,Paolo Graziano,Vito M. Fazio,Lucia A. Muscarella
Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 3 Year: 2014 Page: 382-393
Author(s): Suresh Kumar,Ritesh Agrawal
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 575-576
Author(s): Alberto Ocana, Rosario Serrano, Raul Calero, Atanasio Pandiella